New 2-amino-thiazole-4-acetamides with antiplatelet activity

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• Platelet aggregation is crucial in thrombosis and hemostasis.
• Developing novel antiplatelet agents is vital for cardiovascular disease management.
• Understanding structure-activity relationships aids in designing potent inhibitors.

Purpose of the Study:

• To synthesize and evaluate novel compounds for antiplatelet activity.
• To identify specific structural features responsible for inhibiting platelet aggregation.
• To determine the efficacy of synthesized compounds against various platelet agonists.

Main Methods:

• Synthesis of 23 title compounds using Born test methodology.
• Assessment of antiplatelet activity against collagen, adenosine diphosphate (ADP), adrenaline, and platelet-activating factor (PAF).
• Determination of IC(50) values to quantify inhibitory potency.

Main Results:

• Three compounds (3a, 3b, 3c) showed potent inhibition against collagen (IC(50) < 10 microM).
• Fifteen compounds exhibited activity between 10 and 100 microM against collagen.
• Compound 3e demonstrated strong ADP antagonism (IC(50) = 2.2 nM), 3c inhibited adrenaline (IC(50) = 2.8 nM), and 3n targeted PAF (IC(50) = 0.2 microM).

Conclusions:

• A cyclohexylamino group on a 4-carboxamide moiety is essential for antiplatelet activity.
• The substituent R(1) and the spacer length 'n' significantly influence pharmacological effects.
• Specific compounds show high potency against distinct platelet aggregation pathways, offering potential therapeutic leads.